Hem › Endometriecancer › Alabama › Birmingham
Kliniska studier för Endometriecancer i Birmingham, AL
16 studier för Endometriecancer söker deltagare vid platser i och runt Birmingham (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekryterarFas 2
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
RekryterarFas 3
- GSK Investigational Site, Birmingham
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekryterarFas 3
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekryterarFas 2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RekryterarFas 2
- University of Alabama at Birmingham Cancer Center, Birmingham
DESTINY-PANTUMOUR04
RekryterarObservationsstudie
- Research Site, Birmingham
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
RekryterarFas 1/2
- University of Alabama_6th Ave, Birmingham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekryterarObservationsstudie
- University of Alabama at Birmingham, Birmingham
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekryterarFas 1
- University of Alabama Birmingham, Birmingham
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekryterarFas 1/2
- Children's Hospital of Alabama, Birmingham
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- University of Alabama at Birmingham, Birmingham
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
RekryterarObservationsstudieFriska volontärer välkomna
- University of Alabama at Birmingham, Birmingham
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekryterarFas 1
- University of Alabama at Birmingham, Birmingham
- University of Alabama at Birmingham, IDS Pharmacy, Birmingham
- University of Alabama at Birmingham, Birmingham
- och 1 fler
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekryterarFas 2
- 004, Birmingham
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
RekryterarFas 1/2
- O'Neal Comprehensive Cancer Center at UAB, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Birmingham
Endometriecancer-studier i andra städer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Chicago, IL25 studier
- Columbus, OH25 studier
- Queens, NY25 studier
Andra studier i Birmingham
- Cancer (alla typer)30 studier
- Bröstcancer24 studier
- Övervikt23 studier
- Äggstockscancer23 studier
- Icke-småcellig lungcancer22 studier
- Akut myeloid leukemi21 studier
- Multipelt myelom18 studier
- KOL17 studier
- Hjärt-kärlsjukdom17 studier
- Övervikt16 studier
- Typ 2-diabetes16 studier
- Cystisk fibros16 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.